EBMT NEWSLETTER | July 2015 | Volume 47 - Issue 2

Important dates

Ongoing Clinical Trials

The EBMT CTO is currently working on two recruiting prospective clinical trials in addition to the older trials that are in long-term follow-up.

RACE (PI’s: Regis Peffault de Latour, Antonio M Risitano – Sponsor = EBMT, CTC = Astrid Hoeppener):
  • Approval (CA+EC) in France
  • (Re-)Submissions in Italy, UK and Spain
  • It is planned that the first patients will be recruited into this trial in July 2015
CMV Prophylaxis trial (EBMT Steering Group: Per Ljungman, Rafael Duarte – Sponsor = Merck, CTC = Sue Philpott):
  • Is progressing well.
  • By mid July 2015, over 240 patients had been randomised into the trial.
Other trials are still in long term follow up and/or undergoing analysis.

EBMT CTO will be moving back to ProMISe for the new trials (starting with RACE).

The CT2 committee will open soon for new proposals

Principal Investigators will soon be asked to bring any new ideas for proposals to the CT2 committee using a short proposal template.
Please consult the EBMT website for further information. If you have any questions about the proposal process, please contact alain.barrois@ebmt.org
Bookmark and Share